Regenerex Pharma (RGPX) Debt Ratio (2017 - 2024)

Regenerex Pharma (RGPX) has 8 years of Debt Ratio data on file, last reported at 0.24 in Q1 2024.

• Debt Ratio for Q1 2024 came in at 0.24, down 98.81% year-over-year; the trailing twelve-month figure through Mar 2024 was 0.24 (down 98.81% YoY), and the FY2024 annual result was 0.24, down 98.81% from the prior year.
• Debt Ratio climbed to 0.24 in Q1 2024 per RGPX's latest filing, from 0.0 in the prior quarter.
• Over five years, Debt Ratio peaked at 20.17 in Q1 2023 and troughed at 0.0 in Q3 2023.
• A 5-year average of 7.16 and a median of 8.59 in 2022 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio soared 151525.55% in 2022, then tumbled 99.98% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.52 in 2020, then plunged by 98.3% to 0.01 in 2021, then soared by 151525.55% to 13.28 in 2022, then sank by 99.98% to 0.0 in 2023, then soared by 7213.16% to 0.24 in 2024.
• Business Quant data shows RGPX's Debt Ratio at 0.24 in Q1 2024, 0.0 in Q4 2023, and 0.0 in Q3 2023.